FBXW7 and leukemia: FBW7 mutations have a broad functional role in determining therapeutic responses of cancer cells 8, and can modulate responses to γ secretase inhibitors in leukemia cells 39, to histone deacetylase inhibitors in squamous tumor cells 40, and to antimitotic drugs in CRC cells 41.